[Vaccinations in patients with immunodeficiency or immunosuppressive therapy]

Dtsch Med Wochenschr. 2013 Jan;138(4):145-50. doi: 10.1055/s-0032-1327401. Epub 2013 Jan 15.
[Article in German]

Abstract

Patients with immunodeficiency and patients under immunosuppressive therapy have an increased risk of infectious diseases. Vaccination strategies are needed to protect them from preventable diseases. The underlying disease and severity of the immune impairment may have influence on indications and contra-indications of vaccines. Inactivated vaccines can be administered safely according to the current recommendations of the Permanent Commission on Vaccinations of the Robert-Koch-Institut in Berlin, Germany (STIKO). Depending on the severity of the immune dysfunction, antibody response to vaccinations varies. Where possible, the antibody response following vaccinations should be tested. Previously, attenuated live vaccines were considered to be strictly contra-indicated in immunocompromised patients. Today, the administration of attenuated live vaccines is thought to be possible, depending on the degree and type of immunodeficiency or immunosuppression of the individual.

Publication types

  • Review

MeSH terms

  • Contraindications
  • Humans
  • Immunologic Deficiency Syndromes / complications*
  • Immunologic Deficiency Syndromes / drug therapy*
  • Immunosuppressive Agents / adverse effects*
  • Infections / etiology*
  • Vaccination*

Substances

  • Immunosuppressive Agents